Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)

NCT02267603 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02267603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02267603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
November 25, 2014
Completion date
December 15, 2021
Enrollment
50 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent merkel cell carcinoma, stage iii merkel cell carcinoma ajcc v7, stage iiia merkel cell carcinoma ajcc v7, stage iiib merkel cell carcinoma ajcc v7, stage iv merkel cell carcinoma ajcc v7